United States Age Related Macular Degeneration Industry 2016 Deep Market Research Report

1 Industry Overview

1.1 Definition and Specifications of Age Related Macular Degeneration

1.1.1 Definition of Age Related Macular Degeneration

1.1.2 Specifications of Age Related Macular Degeneration

1.2 Classification of Age Related Macular Degeneration

1.3 Applications of Age Related Macular Degeneration

1.4 Industry Chain Structure of Age Related Macular Degeneration

1.5 Industry Overview of Age Related Macular Degeneration

1.6 Industry Policy Analysis of Age Related Macular Degeneration

1.7 Industry News Analysis of Age Related Macular Degeneration

2 Manufacturing Cost Structure Analysis of Age Related Macular Degeneration

2.1 Bill of Materials (BOM) of Age Related Macular Degeneration

2.2 BOM Price Analysis of Age Related Macular Degeneration

2.3 Labor Cost Analysis of Age Related Macular Degeneration

2.4 Depreciation Cost Analysis of Age Related Macular Degeneration

2.5 Manufacturing Cost Structure Analysis of Age Related Macular Degeneration

2.6 Manufacturing Process Analysis of Age Related Macular Degeneration

2.7 United States Price, Cost and Gross of Age Related Macular Degeneration 2011-2016

3 Technical Data and Manufacturing Plants Analysis

3.1 Capacity and Commercial Production Date of United States Key Manufacturers in 2015

3.2 Manufacturing Plants Distribution of United States Key Age Related Macular Degeneration Manufacturers in 2015

3.3 R&D Status and Technology Source of United States Age Related Macular Degeneration Key Manufacturers in 2015

3.4 Raw Materials Sources Analysis of United States Age Related Macular Degeneration Key Manufacturers in 2015

4 Production Analysis of Age Related Macular Degeneration by Regions, Type, and Applications

4.1 United States Production of Age Related Macular Degeneration by Regions 2011-2016

4.2 United States Production of Age Related Macular Degeneration by Type 2011-2016

4.3 United States Sales of Age Related Macular Degeneration by Applications 2011-2016

4.4 Price Analysis of United States Age Related Macular Degeneration Key Manufacturers in 2015

4.5 United States Capacity, Production, Import, Export, Sales, Price, Cost and Revenue of Age Related Macular Degeneration 2011-2016

5 Consumption Volume and Consumption Value Analysis of Age Related Macular Degeneration by Regions

5.1 United States Consumption Volume of Age Related Macular Degeneration by Regions 2011-2016

5.2 United States Consumption Value of Age Related Macular Degeneration by Regions 2011-2016

5.3 United States Consumption Price Analysis of Age Related Macular Degeneration by Regions 2011-2016

6 Analysis of Age Related Macular Degeneration Production, Supply, Sales and Market Status 2011-2016

6.1 Capacity, Production, Sales, and Revenue of Age Related Macular Degeneration 2011-2016

6.2 Production Market Share and Sales Market Share Analysis of Age Related Macular Degeneration 2014-2015

6.3 Sales Overview of Age Related Macular Degeneration 2011-2016

6.4 Supply, Consumption and Gap of Age Related Macular Degeneration 2011-2016

6.5 Import, Export and Consumption of Age Related Macular Degeneration 2011-2016

6.6 Cost, Price, Revenue and Gross Margin of Age Related Macular Degeneration 2011-2016

7 Analysis of Age Related Macular Degeneration Industry Key Manufacturers

7.1 Achillion Pharmaceuticals, Inc.

7.1.1 Company Profile

7.1.2 Product Picture and Specifications

7.1.2.1 Type I

7.1.2.2 Type II

7.1.2.3 Type III

7.1.3 Capacity, Production, Price, Cost, Gross and Revenue

7.1.4 Contact Information

7.2 Bayer AG

7.2.1 Company Profile

7.2.2 Product Picture and Specifications

7.2.2.1 Type I

7.2.2.2 Type II

7.2.2.3 Type III

7.2.3 Capacity, Production, Price, Cost, Gross and Revenue

7.2.4 Contact Information

7.3 Charlesson LLC.

7.3.1 Company Profile

7.3.2 Product Picture and Specifications

7.3.2.1 Type I

7.3.2.2 Type II

7.3.2.3 Type III

7.3.3 Capacity, Production, Price, Cost, Gross and Revenue

7.3.4 Contact Information

7.4 Digna Biotech, S.L.

7.4.1 Company Profile

7.4.2 Product Picture and Specifications

7.4.2.1 Type I

7.4.2.2 Type II

7.4.2.3 Type III

7.4.3 Capacity, Production, Price, Cost, Gross and Revenue

7.4.4 Contact Information

7.5 Eleven Biotherapeutics Inc.

7.5.1 Company Profile

7.5.2 Product Picture and Specifications

7.5.2.1 Type I

7.5.2.2 Type II

7.5.2.3 Type III

7.5.3 Capacity, Production, Price, Cost, Gross and Revenue

7.5.4 Contact Information

7.6 Foamix Pharmaceuticals Ltd.

7.6.1 Company Profile

7.6.2 Product Picture and Specifications

7.6.2.1 Type I

7.6.2.2 Type II

7.6.2.3 Type III

7.6.3 Capacity, Production, Price, Cost, Gross and Revenue

7.6.4 Contact Information

7.7 Gene Signal International SA

7.7.1 Company Profile

7.7.2 Product Picture and Specifications

7.7.2.1 Type I

7.7.2.2 Type II

7.7.2.3 Type III

7.7.3 Capacity, Production, Price, Cost, Gross and Revenue

7.7.4 Contact Information

7.8 HanAll Biopharma Co., Ltd.

7.8.1 Company Profile

7.8.2 Product Picture and Specifications

7.8.2.1 Type I

7.8.2.2 Type II

7.8.2.3 Type III

7.8.3 Capacity, Production, Price, Cost, Gross and Revenue

7.8.4 Contact Information

7.9 Icon Bioscience, Inc.

7.9.1 Company Profile

7.9.2 Product Picture and Specifications

7.9.2.1 Type I

7.9.2.2 Type II

7.9.2.3 Type III

7.9.3 Capacity, Production, Price, Cost, Gross and Revenue

7.9.4 Contact Information

7.10 Johnson & Johnson

7.10.1 Company Profile

7.10.2 Product Picture and Specifications

7.10.2.1 Type I

7.10.2.2 Type II

7.10.2.3 Type III

7.10.3 Capacity, Production, Price, Cost, Gross and Revenue

7.10.4 Contact Information

7.11 Kala Pharmaceuticals, Inc.

7.11.1 Company Profile

7.11.2 Product Picture and Specifications

7.11.2.1 Type I

7.11.2.2 Type II

7.11.2.3 Type III

7.11.3 Capacity, Production, Price, Cost, Gross and Revenue

7.11.4 Contact Information

7.12 Lpath, Inc.

7.12.1 Company Profile

7.12.2 Product Picture and Specifications

7.12.2.1 Type I

7.12.2.2 Type II

7.12.2.3 Type III

7.12.3 Capacity, Production, Price, Cost, Gross and Revenue

7.12.4 Contact Information

7.13 Merz Pharma GmbH & Co. KgaA

7.13.1 Company Profile

7.13.2 Product Picture and Specifications

7.13.2.1 Type I

7.13.2.2 Type II

7.13.2.3 Type III

7.13.3 Capacity, Production, Price, Cost, Gross and Revenue

7.13.4 Contact Information

7.14 Neovacs SA

7.14.1 Company Profile

7.14.2 Product Picture and Specifications

7.14.2.1 Type I

7.14.2.2 Type II

7.14.2.3 Type III

7.14.3 Capacity, Production, Price, Cost, Gross and Revenue

7.14.4 Contact Information

7.15 Ocata Therapeutics, Inc.

7.15.1 Company Profile

7.15.2 Product Picture and Specifications

7.15.2.1 Type I

7.15.2.2 Type II

7.15.2.3 Type III

7.15.3 Capacity, Production, Price, Cost, Gross and Revenue

7.15.4 Contact Information

7.16 PanOptica, Inc.

7.16.1 Company Profile

7.16.2 Product Picture and Specifications

7.16.2.1 Type I

7.16.2.2 Type II

7.16.2.3 Type III

7.16.3 Capacity, Production, Price, Cost, Gross and Revenue

7.16.4 Contact Information

7.17 Pfenex Inc.

7.17.1 Company Profile

7.17.2 Product Picture and Specifications

7.17.2.1 Type I

7.17.2.2 Type II

7.17.2.3 Type III

7.17.3 Capacity, Production, Price, Cost, Gross and Revenue

7.17.4 Contact Information

7.18 Quark Pharmaceuticals, Inc.

7.18.1 Company Profile

7.18.2 Product Picture and Specifications

7.18.2.1 Type I

7.18.2.2 Type II

7.18.2.3 Type III

7.18.3 Capacity, Production, Price, Cost, Gross and Revenue

7.18.4 Contact Information

7.19 R-Tech Ueno, Ltd.

7.19.1 Company Profile

7.19.2 Product Picture and Specifications

7.19.2.1 Type I

7.19.2.2 Type II

7.19.2.3 Type III

7.19.3 Capacity, Production, Price, Cost, Gross and Revenue

7.19.4 Contact Information

7.20 Sumitomo Dainippon Pharma Co., Ltd.

7.20.1 Company Profile

7.20.2 Product Picture and Specifications

7.20.2.1 Type I

7.20.2.2 Type II

7.20.2.3 Type III

7.20.3 Capacity, Production, Price, Cost, Gross and Revenue

7.20.4 Contact Information

7.21 ThromboGenics NV

7.21.1 Company Profile

7.21.2 Product Picture and Specifications

7.21.2.1 Type I

7.21.2.2 Type II

7.21.2.3 Type III

7.21.3 Capacity, Production, Price, Cost, Gross and Revenue

7.21.4 Contact Information

7.22 VasGene Therapeutics, Inc.

7.22.1 Company Profile

7.22.2 Product Picture and Specifications

7.22.2.1 Type I

7.22.2.2 Type II

7.22.2.3 Type III

7.22.3 Capacity, Production, Price, Cost, Gross and Revenue

7.22.4 Contact Information

7.23 Wellstat Ophthalmics Corporation

7.23.1 Company Profile

7.23.2 Product Picture and Specifications

7.23.2.1 Type I

7.23.2.2 Type II

7.23.2.3 Type III

7.23.3 Capacity, Production, Price, Cost, Gross and Revenue

7.23.4 Contact Information

8 Price and Gross Margin Analysis

8.1 Analysis of Price

8.2 Gross Margin Analysis

8.3 Price Comparison by Regions

8.4 Price Analysis of Different Age Related Macular Degeneration Product Types

8.5 Market Share Analysis of Different Age Related Macular Degeneration Price Levels

8.6 Gross Margin Analysis of Different Age Related Macular Degeneration Applications

9 Marketing Trader or Distributor Analysis of Age Related Macular Degeneration

9.1 Marketing Channels Status of Age Related Macular Degeneration

9.2 Traders or Distributors of Age Related Macular Degeneration with Contact Information

9.3 Ex-work Price, Channel Price and End Buyer Price Analysis of Age Related Macular Degeneration

9.4 United States Import, Export and Trade Analysis of Age Related Macular Degeneration

10 Development Trend of Age Related Macular Degeneration Industry 2016-2021

10.1 Capacity and Production Overview of Age Related Macular Degeneration 2016-2021

10.2 Production Market Share by Product Types of Age Related Macular Degeneration 2016-2021

10.3 Sales and Sales Revenue Overview of Age Related Macular Degeneration 2016-2021

10.4 United States Sales of Age Related Macular Degeneration by Applications 2016-2021

10.5 Import, Export and Consumption of Age Related Macular Degeneration 2016-2021

10.6 Cost, Price, Revenue and Gross Margin of Age Related Macular Degeneration 2016-2021

11 Industry Chain Suppliers of Age Related Macular Degeneration with Contact Information

11.1 Major Raw Materials Suppliers of Age Related Macular Degeneration with Contact Information

11.2 Manufacturing Equipment Suppliers of Age Related Macular Degeneration with Contact Information

11.3 Major Players of Age Related Macular Degeneration with Contact Information

11.4 Key Consumers of Age Related Macular Degeneration with Contact Information

11.5 Supply Chain Relationship Analysis of Age Related Macular Degeneration

12 New Project Investment Feasibility Analysis of Age Related Macular Degeneration

12.1 New Project SWOT Analysis of Age Related Macular Degeneration

12.2 New Project Investment Feasibility Analysis of Age Related Macular Degeneration

13 Conclusion of the United States Age Related Macular Degeneration Industry 2016 Market Research Report

Figure Picture of Age Related Macular Degeneration

Table Product Specifications of Age Related Macular Degeneration

Table Classification of Age Related Macular Degeneration

Figure United States Sales Market Share of Age Related Macular Degeneration by Product Types in 2015

Table Applications of Age Related Macular Degeneration

Figure United States Sales Market Share of Age Related Macular Degeneration by Applications in 2015

Figure Industry Chain Structure of Age Related Macular Degeneration

Table United States Industry Overview of Age Related Macular Degeneration

Table Industry Policy of Age Related Macular Degeneration

Table Industry News List of Age Related Macular Degeneration

Table Bill of Materials (BOM) of Age Related Macular Degeneration

Table Bill of Materials (BOM) Price of Age Related Macular Degeneration

Table Labor Cost of Age Related Macular Degeneration

Table Depreciation Cost of Age Related Macular Degeneration

Table Manufacturing Cost Structure Analysis of Age Related Macular Degeneration in 2015

Figure Manufacturing Process Analysis of Age Related Macular Degeneration

Table United States Price Analysis of Age Related Macular Degeneration 2011-2016 (USD/Dose)

Table United States Cost Analysis of Age Related Macular Degeneration 2011-2016 (USD/Dose)

Table United States Gross Analysis of Age Related Macular Degeneration 2011-2016

Table Capacity (K Dose) and Commercial Production Date of United States Age Related Macular Degeneration Key Manufacturers in 2015

Table Manufacturing Plants Distribution of United States Key Age Related Macular Degeneration Manufacturers in 2015

Table R&D Status and Technology Source of United States Age Related Macular Degeneration Key Manufacturers in 2015

Table Raw Materials Sources Analysis of United States and United States Age Related Macular Degeneration Key Manufacturers in 2015

Table United States Production of Age Related Macular Degeneration by Regions 2011-2016 (K Dose)

Table United States Production Market Share of Age Related Macular Degeneration by Regions 2011-2016

Figure United States Production Market Share of Age Related Macular Degeneration by Regions in 2014

Figure United States Production Market Share of Age Related Macular Degeneration by Regions in 2015

Table United States Production of Age Related Macular Degeneration by Types in 2011-2016 (K Dose)

Table United States Production Market Share of Age Related Macular Degeneration by Type in 2011-2016

Figure United States Production Market Share of Age Related Macular Degeneration by Type in 2014

Figure United States Production Market Share of Age Related Macular Degeneration by Type in 2015

Table United States Sales of Age Related Macular Degeneration by Applications 2011-2016 (K Dose)

Table United States Production Market Share of Age Related Macular Degeneration by Applications 2011-2016

Figure United States Production Market Share of Age Related Macular Degeneration by Applications in 2014

Figure United States Production Market Share of Age Related Macular Degeneration by Applications in 2015

Table Price Comparison of United States Age Related Macular Degeneration Key Manufacturers in 2015 (USD/Dose)

Table United States Capacity, Production, Import Export Sales Price , Cost and Revenue (M USD) of Age Related Macular Degeneration 2011-2016

Table United States Consumption Volume of Age Related Macular Degeneration by Regions 2011-2016 (K Dose)

Table United States Consumption Volume Market Share of Age Related Macular Degeneration by Regions 2011-2016

Figure United States Consumption Volume Market Share of Age Related Macular Degeneration by Regions in 2014

Figure United States Consumption Volume Market Share of Age Related Macular Degeneration by Regions in 2015

Table United States Consumption Value of Age Related Macular Degeneration by Regions 2011-2016 (M USD)

Table United States Consumption Value Market Share of Age Related Macular Degeneration by Regions 2011-2016

Figure United States Consumption Value Market Share of Age Related Macular Degeneration by Regions in 2014

Figure United States Consumption Value Market Share of Age Related Macular Degeneration by Regions in 2015

Table Consumption Price of Age Related Macular Degeneration by Regions 2011-2016 (USD/Dose)

Table United States and Major Manufacturers Capacity of Age Related Macular Degeneration 2011-2016 (K Dose)

Table United States Capacity Market Share of Major Age Related Macular Degeneration Manufacturers 2011-2016

Table United States and Major Manufacturers Production of Age Related Macular Degeneration 2011-2016 (K Dose)

Table United States Production Market Share of Major Age Related Macular Degeneration Manufacturers 2011-2016

Table United States and Major Manufacturers Sales of Age Related Macular Degeneration 2011-2016 (K Dose)

Table United States Sales Market Share of Major Age Related Macular Degeneration Manufacturers 2011-2016

Table United States and Major Manufacturers Sales Revenue of Age Related Macular Degeneration 2011-2016 (M USD)

Table United States Sales Revenue Market Share of Major Age Related Macular Degeneration Manufacturers 2011-2016

Figure United States Capacity (K Dose), Production (K Dose) and Growth Rate of Age Related Macular Degeneration 2011-2016

Figure United States Capacity Utilization Rate of Age Related Macular Degeneration 2011-2016

Figure United States Sales Revenue (M USD) and Growth Rate of Age Related Macular Degeneration 2011-2016

Figure United States Production Market Share of Major Age Related Macular Degeneration Manufacturers in 2014

Figure United States Production Market Share of Major Age Related Macular Degeneration Manufacturers in 2015

Figure United States Sales Market Share of Major Age Related Macular Degeneration Manufacturers in 2014

Figure United States Sales Market Share of Major Age Related Macular Degeneration Manufacturers in 2015

Figure United States Sales (K Dose) and Growth Rate of Age Related Macular Degeneration 2011-2016

Table United States Supply, Consumption and Gap of Age Related Macular Degeneration 2011-2016 (K Dose)

Table United States Import, Export and Consumption of Age Related Macular Degeneration 2011-2016 (K Dose)

Table Price of United States Age Related Macular Degeneration Major Manufacturers 2011-2016 (USD/Dose)

Table Gross Margin of United States Age Related Macular Degeneration Major Manufacturers 2011-2016

Table United States and Major Manufacturers Revenue of Age Related Macular Degeneration 2011-2016 (M USD)

Table United States Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Revenue (M USD) and Gross Margin of Age Related Macular Degeneration 2011-2016

Table Achillion Pharmaceuticals, Inc. Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Age Related Macular Degeneration Picture and Specifications of Achillion Pharmaceuticals, Inc.

Table Age Related Macular Degeneration Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Achillion Pharmaceuticals, Inc. 2011-2016

Figure Age Related Macular Degeneration Capacity (K Dose), Production (K Dose) and Growth Rate of Achillion Pharmaceuticals, Inc. 2011-2016

Figure Age Related Macular Degeneration Production (K Dose) and United States Market Share of Achillion Pharmaceuticals, Inc. 2011-2016

Table Achillion Pharmaceuticals, Inc. Age Related Macular Degeneration SWOT Analysis

Table Bayer AG Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Age Related Macular Degeneration Picture and Specifications of Bayer AG

Table Age Related Macular Degeneration Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Bayer AG 2011-2016

Figure Age Related Macular Degeneration Capacity (K Dose), Production (K Dose) and Growth Rate of Bayer AG 2011-2016

Figure Age Related Macular Degeneration Production (K Dose) and United States Market Share of Bayer AG 2011-2016

Table Bayer AG Age Related Macular Degeneration SWOT Analysis

Table Charlesson LLC. Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Age Related Macular Degeneration Picture and Specifications of Charlesson LLC.

Table Age Related Macular Degeneration Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Charlesson LLC. 2011-2016

Figure Age Related Macular Degeneration Capacity (K Dose), Production (K Dose) and Growth Rate of Charlesson LLC. 2011-2016

Figure Age Related Macular Degeneration Production (K Dose) and United States Market Share of Charlesson LLC. 2011-2016

Table Charlesson LLC. Age Related Macular Degeneration SWOT Analysis

Table Digna Biotech, S.L. Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Age Related Macular Degeneration Picture and Specifications of Digna Biotech, S.L.

Table Age Related Macular Degeneration Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Digna Biotech, S.L. 2011-2016

Figure Age Related Macular Degeneration Capacity (K Dose), Production (K Dose) and Growth Rate of Digna Biotech, S.L. 2011-2016

Figure Age Related Macular Degeneration Production (K Dose) and United States Market Share of Digna Biotech, S.L. 2011-2016

Table Digna Biotech, S.L. Age Related Macular Degeneration SWOT Analysis

Table Eleven Biotherapeutics Inc. Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Age Related Macular Degeneration Picture and Specifications of Eleven Biotherapeutics Inc.

Table Age Related Macular Degeneration Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Eleven Biotherapeutics Inc. 2011-2016

Figure Age Related Macular Degeneration Capacity (K Dose), Production (K Dose) and Growth Rate of Eleven Biotherapeutics Inc. 2011-2016

Figure Age Related Macular Degeneration Production (K Dose) and United States Market Share of Eleven Biotherapeutics Inc. 2011-2016

Table Eleven Biotherapeutics Inc. Age Related Macular Degeneration SWOT Analysis

Table Foamix Pharmaceuticals Ltd. Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Age Related Macular Degeneration Picture and Specifications of Foamix Pharmaceuticals Ltd.

Table Age Related Macular Degeneration Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Foamix Pharmaceuticals Ltd. 2011-2016

Figure Age Related Macular Degeneration Capacity (K Dose), Production (K Dose) and Growth Rate of Foamix Pharmaceuticals Ltd. 2011-2016

Figure Age Related Macular Degeneration Production (K Dose) and United States Market Share of Foamix Pharmaceuticals Ltd. 2011-2016

Table Foamix Pharmaceuticals Ltd. Age Related Macular Degeneration SWOT Analysis

Table Gene Signal International SA Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Age Related Macular Degeneration Picture and Specifications of Gene Signal International SA

Table Age Related Macular Degeneration Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Gene Signal International SA 2011-2016

Figure Age Related Macular Degeneration Capacity (K Dose), Production (K Dose) and Growth Rate of Gene Signal International SA 2011-2016

Figure Age Related Macular Degeneration Production (K Dose) and United States Market Share of Gene Signal International SA 2011-2016

Table Gene Signal International SA Age Related Macular Degeneration SWOT Analysis

Table HanAll Biopharma Co., Ltd. Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Age Related Macular Degeneration Picture and Specifications of HanAll Biopharma Co., Ltd.

Table Age Related Macular Degeneration Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of HanAll Biopharma Co., Ltd. 2011-2016

Figure Age Related Macular Degeneration Capacity (K Dose), Production (K Dose) and Growth Rate of HanAll Biopharma Co., Ltd. 2011-2016

Figure Age Related Macular Degeneration Production (K Dose) and United States Market Share of HanAll Biopharma Co., Ltd. 2011-2016

Table HanAll Biopharma Co., Ltd. Age Related Macular Degeneration SWOT Analysis

Table Icon Bioscience, Inc. Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Age Related Macular Degeneration Picture and Specifications of Icon Bioscience, Inc.

Table Age Related Macular Degeneration Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Icon Bioscience, Inc. 2011-2016

Figure Age Related Macular Degeneration Capacity (K Dose), Production (K Dose) and Growth Rate of Icon Bioscience, Inc. 2011-2016

Figure Age Related Macular Degeneration Production (K Dose) and United States Market Share of Icon Bioscience, Inc. 2011-2016

Table Icon Bioscience, Inc. Age Related Macular Degeneration SWOT Analysis

Table Johnson & Johnson Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Age Related Macular Degeneration Picture and Specifications of Johnson & Johnson

Table Age Related Macular Degeneration Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Johnson & Johnson 2011-2016

Figure Age Related Macular Degeneration Capacity (K Dose), Production (K Dose) and Growth Rate of Johnson & Johnson 2011-2016

Figure Age Related Macular Degeneration Production (K Dose) and United States Market Share of Johnson & Johnson 2011-2016

Table Johnson & Johnson Age Related Macular Degeneration SWOT Analysis

Table Kala Pharmaceuticals, Inc. Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Age Related Macular Degeneration Picture and Specifications of Kala Pharmaceuticals, Inc.

Table Age Related Macular Degeneration Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Kala Pharmaceuticals, Inc. 2011-2016

Figure Age Related Macular Degeneration Capacity (K Dose), Production (K Dose) and Growth Rate of Kala Pharmaceuticals, Inc. 2011-2016

Figure Age Related Macular Degeneration Production (K Dose) and United States Market Share of Kala Pharmaceuticals, Inc. 2011-2016

Table Kala Pharmaceuticals, Inc. Age Related Macular Degeneration SWOT Analysis

Table Lpath, Inc. Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Age Related Macular Degeneration Picture and Specifications of Lpath, Inc.

Table Age Related Macular Degeneration Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Lpath, Inc. 2011-2016

Figure Age Related Macular Degeneration Capacity (K Dose), Production (K Dose) and Growth Rate of Lpath, Inc. 2011-2016

Figure Age Related Macular Degeneration Production (K Dose) and United States Market Share of Lpath, Inc. 2011-2016

Table Lpath, Inc. Age Related Macular Degeneration SWOT Analysis

Table Merz Pharma GmbH & Co. KgaA Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Age Related Macular Degeneration Picture and Specifications of Merz Pharma GmbH & Co. KgaA

Table Age Related Macular Degeneration Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Merz Pharma GmbH & Co. KgaA 2011-2016

Figure Age Related Macular Degeneration Capacity (K Dose), Production (K Dose) and Growth Rate of Merz Pharma GmbH & Co. KgaA 2011-2016

Figure Age Related Macular Degeneration Production (K Dose) and United States Market Share of Merz Pharma GmbH & Co. KgaA 2011-2016

Table Merz Pharma GmbH & Co. KgaA Age Related Macular Degeneration SWOT Analysis

Table Neovacs SA Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Age Related Macular Degeneration Picture and Specifications of Neovacs SA

Table Age Related Macular Degeneration Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Neovacs SA 2011-2016

Figure Age Related Macular Degeneration Capacity (K Dose), Production (K Dose) and Growth Rate of Neovacs SA 2011-2016

Figure Age Related Macular Degeneration Production (K Dose) and United States Market Share of Neovacs SA 2011-2016

Table Neovacs SA Age Related Macular Degeneration SWOT Analysis

Table Ocata Therapeutics, Inc. Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Age Related Macular Degeneration Picture and Specifications of Ocata Therapeutics, Inc.

Table Age Related Macular Degeneration Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Ocata Therapeutics, Inc. 2011-2016

Figure Age Related Macular Degeneration Capacity (K Dose), Production (K Dose) and Growth Rate of Ocata Therapeutics, Inc. 2011-2016

Figure Age Related Macular Degeneration Production (K Dose) and United States Market Share of Ocata Therapeutics, Inc. 2011-2016

Table Ocata Therapeutics, Inc. Age Related Macular Degeneration SWOT Analysis

Table PanOptica, Inc. Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Age Related Macular Degeneration Picture and Specifications of PanOptica, Inc.

Table Age Related Macular Degeneration Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of PanOptica, Inc. 2011-2016

Figure Age Related Macular Degeneration Capacity (K Dose), Production (K Dose) and Growth Rate of PanOptica, Inc. 2011-2016

Figure Age Related Macular Degeneration Production (K Dose) and United States Market Share of PanOptica, Inc. 2011-2016

Table PanOptica, Inc. Age Related Macular Degeneration SWOT Analysis

Table Pfenex Inc. Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Age Related Macular Degeneration Picture and Specifications of Pfenex Inc.

Table Age Related Macular Degeneration Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Pfenex Inc. 2011-2016

Figure Age Related Macular Degeneration Capacity (K Dose), Production (K Dose) and Growth Rate of Pfenex Inc. 2011-2016

Figure Age Related Macular Degeneration Production (K Dose) and United States Market Share of Pfenex Inc. 2011-2016

Table Pfenex Inc. Age Related Macular Degeneration SWOT Analysis

Table Quark Pharmaceuticals, Inc. Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Age Related Macular Degeneration Picture and Specifications of Quark Pharmaceuticals, Inc.

Table Age Related Macular Degeneration Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Quark Pharmaceuticals, Inc. 2011-2016

Figure Age Related Macular Degeneration Capacity (K Dose), Production (K Dose) and Growth Rate of Quark Pharmaceuticals, Inc. 2011-2016

Figure Age Related Macular Degeneration Production (K Dose) and United States Market Share of Quark Pharmaceuticals, Inc. 2011-2016

Table Quark Pharmaceuticals, Inc. Age Related Macular Degeneration SWOT Analysis

Table R-Tech Ueno, Ltd. Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Age Related Macular Degeneration Picture and Specifications of R-Tech Ueno, Ltd.

Table Age Related Macular Degeneration Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of R-Tech Ueno, Ltd. 2011-2016

Figure Age Related Macular Degeneration Capacity (K Dose), Production (K Dose) and Growth Rate of R-Tech Ueno, Ltd. 2011-2016

Figure Age Related Macular Degeneration Production (K Dose) and United States Market Share of R-Tech Ueno, Ltd. 2011-2016

Table R-Tech Ueno, Ltd. Age Related Macular Degeneration SWOT Analysis

Table Sumitomo Dainippon Pharma Co., Ltd. Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Age Related Macular Degeneration Picture and Specifications of Sumitomo Dainippon Pharma Co., Ltd.

Table Age Related Macular Degeneration Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Sumitomo Dainippon Pharma Co., Ltd. 2011-2016

Figure Age Related Macular Degeneration Capacity (K Dose), Production (K Dose) and Growth Rate of Sumitomo Dainippon Pharma Co., Ltd. 2011-2016

Figure Age Related Macular Degeneration Production (K Dose) and United States Market Share of Sumitomo Dainippon Pharma Co., Ltd. 2011-2016

Table Sumitomo Dainippon Pharma Co., Ltd. Age Related Macular Degeneration SWOT Analysis

Table ThromboGenics NV Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Age Related Macular Degeneration Picture and Specifications of ThromboGenics NV

Table Age Related Macular Degeneration Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of ThromboGenics NV 2011-2016

Figure Age Related Macular Degeneration Capacity (K Dose), Production (K Dose) and Growth Rate of ThromboGenics NV 2011-2016

Figure Age Related Macular Degeneration Production (K Dose) and United States Market Share of ThromboGenics NV 2011-2016

Table ThromboGenics NV Age Related Macular Degeneration SWOT Analysis

Table VasGene Therapeutics, Inc. Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Age Related Macular Degeneration Picture and Specifications of VasGene Therapeutics, Inc.

Table Age Related Macular Degeneration Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of VasGene Therapeutics, Inc. 2011-2016

Figure Age Related Macular Degeneration Capacity (K Dose), Production (K Dose) and Growth Rate of VasGene Therapeutics, Inc. 2011-2016

Figure Age Related Macular Degeneration Production (K Dose) and United States Market Share of VasGene Therapeutics, Inc. 2011-2016

Table VasGene Therapeutics, Inc. Age Related Macular Degeneration SWOT Analysis

Table Wellstat Ophthalmics Corporation Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Age Related Macular Degeneration Picture and Specifications of Wellstat Ophthalmics Corporation

Table Age Related Macular Degeneration Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Wellstat Ophthalmics Corporation 2011-2016

Figure Age Related Macular Degeneration Capacity (K Dose), Production (K Dose) and Growth Rate of Wellstat Ophthalmics Corporation 2011-2016

Figure Age Related Macular Degeneration Production (K Dose) and United States Market Share of Wellstat Ophthalmics Corporation 2011-2016

Table Wellstat Ophthalmics Corporation Age Related Macular Degeneration SWOT Analysis

Table Age Related Macular Degeneration Price by Regions 2011-2016

Table Age Related Macular Degeneration Price by Product Types 2011-2016

Table Age Related Macular Degeneration Price by Companies 2011-2016

Table Age Related Macular Degeneration Gross Margin by Companies 2011-2016

Table Price Comparison of Age Related Macular Degeneration by Regions 2011-2016 (USD/Dose)

Table Price of Different Age Related Macular Degeneration Product Types (USD/Dose)

Table Market Share of Different Age Related Macular Degeneration Price Level

Table Gross Margin of Different Age Related Macular Degeneration Applications

Table Marketing Channels Status of Age Related Macular Degeneration

Table Traders or Distributors of Age Related Macular Degeneration with Contact Information

Table Ex-work Price, Channel Price and End Buyer Price of Age Related Macular Degeneration (USD/Dose) in 2015

Table United States Import, Export, and Trade of Age Related Macular Degeneration (K Dose)

Figure United States Capacity (K Dose), Production (K Dose) and Growth Rate of Age Related Macular Degeneration 2016-2021

Figure United States Capacity Utilization Rate of Age Related Macular Degeneration 2016-2021

Table United States Age Related Macular Degeneration Production by Type 2016-2021 (K Dose)

Table United States Age Related Macular Degeneration Production Market Share by Type 2016-2021

Figure United States Production Market Share of Age Related Macular Degeneration by Type in 2021

Figure United States Sales (K Dose) and Growth Rate of Age Related Macular Degeneration 2016-2021

Figure United States Sales Revenue (Million USD) and Growth Rate of Age Related Macular Degeneration 2016-2021

Figure United States Sales of Age Related Macular Degeneration by Applications 2016-2021 (K Dose)

Table United States Production Market Share of Age Related Macular Degeneration by Applications 2016-2021

Figure United States Production Market Share of Age Related Macular Degeneration by Applications in 2021

Table United States Production, Import, Export and Consumption of Age Related Macular Degeneration 2016-2021 (K Dose)

Table United States Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Revenue (M USD) and Gross Margin of Age Related Macular Degeneration 2016-2021

Table Major Raw Materials Suppliers of Age Related Macular Degeneration with Contact Information

Table Manufacturing Equipment Suppliers of Age Related Macular Degeneration with Contact Information

Table Major Players of Age Related Macular Degeneration with Contact Information

Table Key Consumers of Age Related Macular Degeneration with Contact Information

Table Supply Chain Relationship Analysis of Age Related Macular Degeneration

Table New Project SWOT Analysis of Age Related Macular Degeneration

Table New Project Investment Feasibility Analysis of Age Related Macular Degeneration

Table Part of Interviewees Record List